Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 150

1.

The reverse Warburg effect in osteosarcoma.

Sotgia F, Martinez-Outschoorn UE, Lisanti MP.

Oncotarget. 2014 Sep 30;5(18):7982-3. No abstract available.

PMID:
25513437
[PubMed - in process]
2.

The reverse Warburg effect in osteosarcoma.

Sotgia F, Martinez-Outschoorn UE, Lisanti MP.

Oncotarget. 2014 Sep 30;5(18):7982-3. No abstract available.

PMID:
25478627
[PubMed - in process]
Free PMC Article
3.

Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1/2 inhibition.

Lamb R, Harrison H, Hulit J, Smith DL, Lisanti MP, Sotgia F.

Oncotarget. 2014 Nov 15. [Epub ahead of print]

PMID:
25415228
[PubMed - as supplied by publisher]
Free Article
4.

Metabolic asymmetry in cancer: a "balancing act" that promotes tumor growth.

Martinez-Outschoorn UE, Sotgia F, Lisanti MP.

Cancer Cell. 2014 Jul 14;26(1):5-7. doi: 10.1016/j.ccr.2014.06.021.

PMID:
25026205
[PubMed - indexed for MEDLINE]
5.

17β-estradiol regulates giant vesicle formation via estrogen receptor-alpha in human breast cancer cells.

Wright PK, Jones SB, Ardern N, Ward R, Clarke RB, Sotgia F, Lisanti MP, Landberg G, Lamb R.

Oncotarget. 2014 May 30;5(10):3055-65.

PMID:
24931391
[PubMed - in process]
Free PMC Article
6.

Tumor microenvironment and metabolic synergy in breast cancers: critical importance of mitochondrial fuels and function.

Martinez-Outschoorn U, Sotgia F, Lisanti MP.

Semin Oncol. 2014 Apr;41(2):195-216. doi: 10.1053/j.seminoncol.2014.03.002. Epub 2014 Mar 5. Review.

PMID:
24787293
[PubMed - indexed for MEDLINE]
7.

CAPER, a novel regulator of human breast cancer progression.

Mercier I, Gonzales DM, Quann K, Pestell TG, Molchansky A, Sotgia F, Hulit J, Gandara R, Wang C, Pestell RG, Lisanti MP, Jasmin JF.

Cell Cycle. 2014 Apr 15;13(8):1256-64. doi: 10.4161/cc.28156. Epub 2014 Feb 17.

PMID:
24621503
[PubMed - in process]
8.

Catabolic cancer-associated fibroblasts transfer energy and biomass to anabolic cancer cells, fueling tumor growth.

Martinez-Outschoorn UE, Lisanti MP, Sotgia F.

Semin Cancer Biol. 2014 Apr;25:47-60. doi: 10.1016/j.semcancer.2014.01.005. Epub 2014 Jan 28. Review.

PMID:
24486645
[PubMed - indexed for MEDLINE]
9.

JNK1 stress signaling is hyper-activated in high breast density and the tumor stroma: connecting fibrosis, inflammation, and stemness for cancer prevention.

Lisanti MP, Tsirigos A, Pavlides S, Reeves KJ, Peiris-Pagès M, Chadwick AL, Sanchez-Alvarez R, Lamb R, Howell A, Martinez-Outschoorn UE, Sotgia F.

Cell Cycle. 2014 Feb 15;13(4):580-99. doi: 10.4161/cc.27379. Epub 2013 Dec 5.

PMID:
24434780
[PubMed - in process]
10.

Stromal glycolysis and MCT4 are hallmarks of DCIS progression to invasive breast cancer.

Lisanti MP, Sotgia F, Pestell RG, Howell A, Martinez-Outschoorn UE.

Cell Cycle. 2013 Sep 15;12(18):2935-6. doi: 10.4161/cc.26280. Epub 2013 Aug 27. No abstract available.

PMID:
23989616
[PubMed - indexed for MEDLINE]
Free Article
11.

Reverse Warburg effect in a patient with aggressive B-cell lymphoma: is lactic acidosis a paraneoplastic syndrome?

Martinez-Outschoorn UE, Whitaker-Menezes D, Valsecchi M, Martinez-Cantarin MP, Dulau-Florea A, Gong J, Howell A, Flomenberg N, Pestell RG, Wagner J, Arana-Yi C, Sharma M, Sotgia F, Lisanti MP.

Semin Oncol. 2013 Aug;40(4):403-18. doi: 10.1053/j.seminoncol.2013.04.016. No abstract available.

PMID:
23972703
[PubMed - indexed for MEDLINE]
12.

Carbonic anhydrase 9 (CA9) and redox signaling in cancer-associated fibroblasts: therapeutic implications.

Chadwick AL, Howell A, Sotgia F, Lisanti MP.

Cell Cycle. 2013 Aug 15;12(16):2534-5. doi: 10.4161/cc.25842. Epub 2013 Jul 30. No abstract available.

PMID:
23907127
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Cancer metabolism: new validated targets for drug discovery.

Sotgia F, Martinez-Outschoorn UE, Lisanti MP.

Oncotarget. 2013 Aug;4(8):1309-16.

PMID:
23896568
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Oncogenes induce the cancer-associated fibroblast phenotype: metabolic symbiosis and "fibroblast addiction" are new therapeutic targets for drug discovery.

Lisanti MP, Martinez-Outschoorn UE, Sotgia F.

Cell Cycle. 2013 Sep 1;12(17):2723-32. doi: 10.4161/cc.25695. Epub 2013 Jul 30. Review.

PMID:
23860382
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment: RAS and NFκB target stromal MCT4.

Martinez-Outschoorn UE, Curry JM, Ko YH, Lin Z, Tuluc M, Cognetti D, Birbe RC, Pribitkin E, Bombonati A, Pestell RG, Howell A, Sotgia F, Lisanti MP.

Cell Cycle. 2013 Aug 15;12(16):2580-97. doi: 10.4161/cc.25510. Epub 2013 Jul 8.

PMID:
23860378
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Caloric restriction augments radiation efficacy in breast cancer.

Saleh AD, Simone BA, Palazzo J, Savage JE, Sano Y, Dan T, Jin L, Champ CE, Zhao S, Lim M, Sotgia F, Camphausen K, Pestell RG, Mitchell JB, Lisanti MP, Simone NL.

Cell Cycle. 2013 Jun 15;12(12):1955-63. doi: 10.4161/cc.25016. Epub 2013 May 21.

PMID:
23708519
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Caveolin-1 is a negative regulator of tumor growth in glioblastoma and modulates chemosensitivity to temozolomide.

Quann K, Gonzales DM, Mercier I, Wang C, Sotgia F, Pestell RG, Lisanti MP, Jasmin JF.

Cell Cycle. 2013 May 15;12(10):1510-20. doi: 10.4161/cc.24497. Epub 2013 Apr 17.

PMID:
23598719
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer.

Curry JM, Tuluc M, Whitaker-Menezes D, Ames JA, Anantharaman A, Butera A, Leiby B, Cognetti DM, Sotgia F, Lisanti MP, Martinez-Outschoorn UE.

Cell Cycle. 2013 May 1;12(9):1371-84. doi: 10.4161/cc.24092. Epub 2013 Apr 10.

PMID:
23574725
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Compartment-specific activation of PPARγ governs breast cancer tumor growth, via metabolic reprogramming and symbiosis.

Avena P, Anselmo W, Whitaker-Menezes D, Wang C, Pestell RG, Lamb RS, Hulit J, Casaburi I, Andò S, Martinez-Outschoorn UE, Lisanti MP, Sotgia F.

Cell Cycle. 2013 May 1;12(9):1360-70. doi: 10.4161/cc.24289. Epub 2013 Apr 10.

PMID:
23574724
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Cav1 inhibits benign skin tumor development in a two-stage carcinogenesis model by suppressing epidermal proliferation.

Trimmer C, Sotgia F, Lisanti MP, Capozza F.

Am J Transl Res. 2013;5(1):80-91. Epub 2013 Jan 21.

PMID:
23390568
[PubMed]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk